Matinas BioPharma Holdings, Inc. MTNB
AMEX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | 0.00 | 0.00 | 85.00K | 2.46M | 4.70M |
| Gross Profit | 0.00 | 0.00 | -85.00K | -2.46M | -4.70M |
| SG&A Expenses | 6.67M | 6.95M | 6.88M | 6.94M | 7.50M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 6.67M | 6.95M | 6.96M | 9.40M | 12.20M |
| Operating Income | -6.67M | -6.95M | -6.96M | -9.40M | -12.20M |
| Income Before Tax | -6.69M | -10.61M | -10.35M | -16.95M | -19.69M |
| Income Tax Expenses | -- | -- | -- | -80.00K | -80.00K |
| Earnings from Continuing Operations | -6.69 | -10.61 | -10.35 | -16.87 | -19.61 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -6.69M | -10.61M | -10.35M | -16.87M | -19.61M |
| EBIT | -6.67M | -6.95M | -6.96M | -9.40M | -12.20M |
| EBITDA | -6.65M | -6.92M | -6.92M | -9.28M | -11.99M |
| EPS Basic | -18.10 | -30.46 | -30.85 | -51.14 | -57.94 |
| Normalized Basic EPS | -10.47 | -11.70 | -12.48 | -17.26 | -22.57 |
| EPS Diluted | -18.10 | -30.46 | -30.85 | -51.14 | -57.94 |
| Normalized Diluted EPS | -10.47 | -11.70 | -12.48 | -17.26 | -22.57 |
| Average Basic Shares Outstanding | 1.64M | 1.55M | 1.46M | 1.38M | 1.35M |
| Average Diluted Shares Outstanding | 1.64M | 1.55M | 1.46M | 1.38M | 1.35M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |